ANABVSLRCX• 6 Months (Normalized)
ANAB vs LRCX (AnaptysBio Inc. vs Lam Research Corporation)
Showing Closing Date Range from Mar, 15 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANAB Performance $53.87
+24.74%
AnaptysBio Inc.
Normalized Baseline0.00%
LRCX Performance $298.22
+35.93%
Lam Research Corporation
Normalized Baseline0.00%
Alpha Spread Margin LRCX LEADS
-11.19%
LRCX outperforming by 11.19%
ANABLRCX
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANAB LRCX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | ANAB Price | ANAB Gain (%) | LRCX Price | LRCX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $53.87 | +24.74% | $298.22 | +35.93% | -11.19% |
| Sep 10, 2026 | $55.16 | +27.72% | $298.01 | +35.83% | -8.11% |
| Sep 09, 2026 | $55.70 | +28.97% | $315.84 | +43.96% | -14.99% |
| Sep 08, 2026 | $56.60 | +31.06% | $320.42 | +46.04% | -14.98% |
| Sep 04, 2026 | $56.80 | +31.52% | $307.65 | +40.22% | -8.70% |
| Sep 03, 2026 | $57.46 | +33.05% | $292.66 | +33.39% | -0.34% |
| Sep 02, 2026 | $55.84 | +29.30% | $288.32 | +31.41% | -2.11% |
| Sep 01, 2026 | $55.28 | +28.00% | $290.20 | +32.27% | -4.27% |
| Aug 31, 2026 | $57.03 | +32.05% | $301.49 | +37.42% | -5.37% |
| Aug 28, 2026 | $56.28 | +30.32% | $301.90 | +37.60% | -7.28% |
| Aug 27, 2026 | $57.29 | +32.66% | $318.58 | +45.21% | -12.55% |
| Aug 26, 2026 | $58.00 | +34.30% | $312.88 | +42.61% | -8.31% |
| Aug 25, 2026 | $58.37 | +35.16% | $314.66 | +43.42% | -8.26% |
| Aug 24, 2026 | $58.44 | +35.32% | $310.17 | +41.37% | -6.05% |
| Aug 21, 2026 | $57.74 | +33.70% | $314.00 | +43.12% | -9.42% |
Page 1 of 9